Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 3/20 | 0.46 |
| ▸ | ADH1A | P07327 | 3/20 | 0.46 |
| ▸ | ADH7 | P40394 | 3/20 | 0.46 |
| ▸ | ADH1C | P00326 | 2/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | ADH4 | P08319 | 1/20 | 0.44 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.40 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.40 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.40 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20407305 | 1.00 | — | — | |
| SCHEMBL2183070 | 0.92 | ADH1B (0.45) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL3321937 | 0.91 | ADH1B (0.43) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL1306927 | 0.91 | HRH3 (0.46) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL3931949 | 0.90 | ADH1B (0.48) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL3954101 | 0.90 | ALDH1A1 (0.39) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL3950791 | 0.90 | ADH1B (0.54) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL3949507 | 0.90 | ADH1B (0.39) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL1307277 | 0.89 | HRH3 (0.50) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL1781619 | 0.86 | HRH3 (0.52) | ADH1BADH1AADH7ADH1CEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9533937-B2 | Use of metal scavengers for removal of ruthenium residues | APEIRON SYNTHESIS S.A. (PL) | 2017-01-03 | — | — | US | disclosed |
| EP-2882877-B1 | USE OF METAL SCAVENGERS FOR REMOVAL OF RUTHENIUM RESIDUES | APEIRON SYNTHESIS SA (PL) | 2016-11-30 | — | — | EP | disclosed |
| US-20160297742-A1 | USE OF METAL SCAVENGERS FOR REMOVAL OF RUTHENIUM RESIDUES | APEIRON SYNTHESIS S.A. (PL) | 2016-10-13 | — | — | US | disclosed |
| US-20160297742-A1 | USE OF METAL SCAVENGERS FOR REMOVAL OF RUTHENIUM RESIDUES | APEIRON SYNTHESIS S.A. (PL) | 2016-10-13 | — | — | US | disclosed |
| WO-2014174501-A2 | USE OF METAL SCAVENGERS FOR REMOVAL OF RUTHENIUM RESIDUES | APEIRON SYNTHESIS S.A. (PL) | 2014-10-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160297742-A1 | USE OF METAL SCAVENGERS FOR REMOVAL OF RUTHENIUM RESIDUES | SLC40A1, ABCB7, TFRC | ADH1B 1459/4885ADH1A 1801/4885ADH7 531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.